Goldenwing has collaborated with manufacturers worldwide to accelerate the path to commercialization for a wide range of embolism devices. Expedited preclinical research for embolism devices helps manufacturers move development forward as efficiently as possible.

1. Embolization Devices

· Embolic Agents: Materials like coils, particles, or liquids used to occlude blood vessels.

· Balloon Occlusion Devices: Balloons designed to temporarily block blood flow in vessels.

· Radiofrequency Ablation Devices: Tools that use heat to destroy tissue and induce embolism.

2. Vascular Access Devices

· Catheters: Used for delivering embolic agents or for diagnostic purposes.

· Sheaths: Introducer sheaths for vascular access.

3. Filters

· Inferior Vena Cava (IVC) Filters: Devices to prevent emboli from reaching the lungs.

· Pulmonary Filters: Devices to capture emboli in the pulmonary arteries.

4. Stents and Stent-Grafts

· Self-expanding Stents: Used to maintain vessel patency in areas at risk of embolism.

· Stent-Grafts: Hybrid devices that combine stenting and grafting to repair vascular damage.

5. Mechanical Circulatory Support Devices

· Extracorporeal Membrane Oxygenation (ECMO): To assess effects on embolism during circulatory support.

· Left Ventricular Assist Devices (LVADs): Evaluating how they manage blood flow and potential embolism.

6. Imaging Devices

· Ultrasound Systems: For real-time imaging of embolism effects.

· Fluoroscopy Systems: To visualize device deployment and embolization processes.

· CT and MRI Scanners: For detailed imaging of embolism and device placement.

7. Surgical Instruments

· Clips and Staples: For vessel closure and assessing induced embolism.

· Scissors and Graspers: For manipulating tissues and vessels during procedures.

8. Biomarkers and Monitoring Devices

· Hemodynamic Monitors: To track changes in blood flow and pressure.

· Coagulation Monitors: Assessing the coagulation status and its effect on embolism.

9. Implantable Devices

· Pacemakers and Cardiac Resynchronization Therapy Devices: Evaluating impact on cardiac output and potential embolism risks.

· Implantable Cardioverter Defibrillators (ICDs): Assessing interactions with embolism risks.

10. Drug Delivery Systems

· Targeted Drug Delivery Devices: Systems for localized treatment of embolic conditions.

· Combination Devices: Integrating drug delivery with embolization mechanisms.

11. Experimental Models

· Custom Devices: Tailored devices for specific types of embolism research (e.g., thrombus simulation devices).